Access the full text.
Sign up today, get DeepDyve free for 14 days.
Drug Safety and Risk Management Advisory Committee meeting.
H. Birnbaum, R. Kessler, Sarah Lowe, K. Secnik, P. Greenberg, S. Leong, A. Swensen (2005)
Costs of attention deficit–hyperactivity disorder (ADHD) in the US: excess costs of persons with ADHD and their family members in 2000Current Medical Research and Opinion, 21
MT Cooney, E Vartiainen, T Laatikainen, A Juolevi, A Dudina, IM Graham (2010)
Elevated resting heart rate is an independent risk factor for cardiovascular disease in healthy men and women [published correction appears in Am Heart J. 2010;160(1):208]., 159
M. Gould, B. Walsh, J. Munfakh, M. Kleinman, Naihua Duan, M. Olfson, L. Greenhill, T. Cooper (2009)
Sudden death and use of stimulant medications in youths.The American journal of psychiatry, 166 9
L. Habel, William Cooper, Colin Sox, K. Chan, Bruce Fireman, P. Arbogast, T. Cheetham, Virginia Quinn, S. Dublin, Denise Boudreau, Susan Andrade, P. Pawloski, Marsha Raebel, David Smith, N. Achacoso, Connie Uratsu, Alan Go, S. Sidney, Mai Nguyen-Huynh, Wayne Ray, Joe Selby (2011)
ADHD medications and risk of serious cardiovascular events in young and middle-aged adults.JAMA, 306 24
A. Winterstein, T. Gerhard, J. Shuster, A. Saidi (2009)
Cardiac Safety of Methylphenidate Versus Amphetamine Salts in the Treatment of ADHDPediatrics, 124
S. Bejerot, E. Rydén, C. Arlinde (2010)
Two-year outcome of treatment with central stimulant medication in adult attention-deficit/hyperactivity disorder: a prospective study.The Journal of clinical psychiatry, 71 12
A. Winterstein, T. Gerhard, J. Shuster, Michael Johnson, J. Zito, A. Saidi (2007)
Cardiac Safety of Central Nervous System Stimulants in Children and Adolescents With Attention-Deficit/Hyperactivity DisorderPediatrics, 120
V. Vetter, J. Elia, C. Erickson, S. Berger, N. Blum, K. Uzark, C. Webb (2008)
Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee andCirculation, 117 18
L. Adler, B. Zimmerman, H. Starr, S. Silber, J. Palumbo, C. Orman, T. Spencer (2009)
Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Double-Blind, Parallel Group, Dose-Escalation StudyJournal of Clinical Psychopharmacology, 29
VL Vetter, J Elia, C Erickson (2008)
Cardiovascular monitoring of children and adolescents with heart disease receiving medications for attention deficit/hyperactivity disorder [corrected]: a scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young Congenital Cardiac Defects Committee and the Council on Cardiovascular Nursing., 117
D. Nutt, K. Fone, P. Asherson, D. Bramble, P. Hill, K. Matthews, Kelly Morris, P. Santosh, E. Sonuga-Barke, E. Taylor, M. Weiss, S. Young (2007)
Evidence-based guidelines for management of attention-deficit/hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for PsychopharmacologyJournal of Psychopharmacology, 21
R. Graaf, Ronald Kessler, J. Fayyad, M. Have, J. Alonso, M. Angermeyer, G. Borges, Koen, Demyttenaere, I. Gasquet, G. Girolamo, Josep Maria, Haro, R. Jin, E. Karam, J. Ormel, José, Posada-Villa (2008)
The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey InitiativeOccupational and Environmental Medicine, 65
R. Kessler (2006)
The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication.The American journal of psychiatry, 163 4
W. Cooper, L. Habel, C. Sox, K. Chan, P. Arbogast, T. Cheetham, K. Murray, V. Quinn, C. Stein, S. Callahan, B. Fireman, F. Fish, H. Kirshner, A. O'Duffy, F. Connell, W. Ray (2011)
ADHD drugs and serious cardiovascular events in children and young adults.The New England journal of medicine, 365 20
M. Rösler, R. Fischer, R. Ammer, C. Ose, W. Retz, on group (2009)
A randomised, placebo-controlled, 24-week, study of low-dose extended-release methylphenidate in adults with attention-deficit/hyperactivity disorderEuropean Archives of Psychiatry and Clinical Neuroscience, 259
Editorials represent the opinions EDITORIAL of the authors and JAMA and not those of the American Medical Association. ONLINE FIRST Some Heartening News scribed ADHD medication, and these factors are associated Philip Shaw, MD, PhD with better health. The authors discussed this healthy-user bias because they found that ADHD medications had an ap- EW MEDICATIONS HAVE RECEIVED AS MUCH PUBLIC parent protective association with the risk of stroke and sud- scrutiny as those used for attention-deficit/ den cardiac death. However, these findings were elimi- hyperactivity disorder (ADHD). The most serious nated when further analyses that controlled for additional Fconcerns have centered on cardiovascular risk. The 1 demographic characteristics and cardiovascular health were study by Habel and colleagues in this issue of JAMA com- conducted. Likewise, the authors found that an apparently pared approximately150 000 adults prescribed ADHD medi- significant increase in risk of myocardial infarction was also cation with approximately 300 000 nonusers and found no rendered null when the same variables were considered. evidence of a link between ADHD medications and myo- One of the most elegant features of the study is the sec- cardial infarction, sudden cardiac death, or stroke. ond approach the authors adopted to deal
JAMA – American Medical Association
Published: Dec 28, 2011
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.